Showing results (161-170 of 216) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|March 21, 2024
Proteomics landscape and machine learning prediction of long-term response to splenectomy in primary immune thrombocytopeniaTing Sun, Jia Chen, Yuan Xu, et al.
Thrombosis Research|April 23, 2023
Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemiaHuan Dong, Huiyuan Li, Lijun Fang, et al.
British Journal of Haematology|January 28, 2023
Molecular analysis of phenotypic heterogeneity in JAK2V617F-positive myeloproliferative neoplasms reveals a potential target for therapyWenjing Gu, Jingyuan Tong, Rongfeng Fu, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2026
Bone Marrow Proteomic Profiling Reveals TMEM109 as a Biomarker for Relapse in Thrombotic Thrombocytopenic PurpuraQing Wen, Jia Chen, Ting Sun, et al.
Nature Medicine|April 29, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trialHuiyuan Li, Yuan Xu, Yunfei Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Lupus anticoagulant: two cases report and literature review]Yang Li, Ming' en Lyu, Feng Xue, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 8, 2022
Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia ARunhui Wu, Xiaoling Wang, Xielan Zhao, et al.
International Journal of Hematology|July 4, 2012
A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopeniaShujie Wang, Renchi Yang, Ping Zou, et al.
Haematologica|July 11, 2019
Multilevel defects in the hematopoietic niche in essential thrombocythemiaTing Sun, Mankai Ju, Xinyue Dai, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 7, 2016
The Efficacy of Recombinant FVIII Low-Dose Prophylaxis in Chinese Pediatric Patients With Severe Hemophilia A: A Retrospective Analysis From the ReCARE StudyWanru Yao, Juan Xiao, Xiaoling Cheng, et al.
Pageof 22